Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
CNY | Fiscal Year Ending | | Latest |
(in millions) | Dec-14 | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Jan-22 | Jan-23 | Dec-23 | | Sep-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 2,016 | 2,231 | 2,569 | 4,049 | 4,042 | 4,446 | 4,254 | 4,815 | 5,994 | 5,933 | | 7,307 |
% Growth | NA | 10.7% | 15.1% | 57.6% | -0.2% | 10.0% | -4.3% | 13.2% | 24.5% | -1.0% | | |
| | | | | | | | | | | | |
Cost of Revenue | (1,589) | (1,810) | (2,101) | (3,433) | (3,670) | (3,672) | (3,602) | (4,348) | (5,294) | (5,069) | | (6,282) |
Gross Profit | 427 | 421 | 468 | 616 | 372 | 773 | 652 | 467 | 700 | 864 | | 1,025 |
% Revenue | 21.2% | 18.9% | 18.2% | 15.2% | 9.2% | 17.4% | 15.3% | 9.7% | 11.7% | 14.6% | | 14.0% |
| | | | | | | | | | | | |
Research and Development | (103) | (128) | (152) | (181) | (207) | (190) | (206) | (252) | (274) | (319) | | (407) |
Selling and Marketing | (82) | (94) | (100) | (121) | (111) | (94) | (43) | (46) | (50) | (67) | | (93) |
General and Admin | (186) | (230) | (266) | (127) | (120) | (166) | (192) | (186) | (218) | (206) | | (284) |
Other Inc / (Exp) | 76 | 112 | 133 | (32) | (154) | (26) | 5 | 51 | 21 | (33) | | (5) |
Total Operating Exp | (294) | (340) | (385) | (462) | (592) | (475) | (436) | (433) | (521) | (626) | | (789) |
| | | | | | | | | | | | |
Operating Income | 132 | 81 | 84 | 154 | (220) | 298 | 216 | 34 | 179 | 239 | | 236 |
% Revenue | 6.6% | 3.6% | 3.3% | 3.8% | -5.4% | 6.7% | 5.1% | 0.7% | 3.0% | 4.0% | | 3.2% |
| | | | | | | | | | | | |
Interest Expense | (25) | (22) | (21) | 0 | (49) | 80 | (17) | (17) | (16) | 112 | | 44 |
Pre-tax Income | 107 | 59 | 63 | 154 | (268) | 378 | 199 | 16 | 163 | 350 | | 280 |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | (16) | (15) | (7) | (26) | 48 | (29) | (12) | 24 | 16 | 11 | | 13 |
Net Income to Company | 91 | 44 | 55 | 128 | (221) | 350 | 187 | 40 | 179 | 361 | | 293 |
% Margin | 4.5% | 2.0% | 2.2% | 3.2% | -5.5% | 7.9% | 4.4% | 0.8% | 3.0% | 6.1% | | 4.0% |
| | | | | | | | | | | | |
Minority Interest in Earnings | 2 | 4 | 5 | 3 | 2 | 3 | (1) | (0) | (1) | (0) | | (0) |
Net Income to Stockholders | 93 | 48 | 60 | 131 | (219) | 353 | 187 | 40 | 178 | 361 | | 293 |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | 93 | 48 | 60 | 131 | (219) | 353 | 187 | 40 | 178 | 361 | | 293 |
% Margin | 4.6% | 2.1% | 2.4% | 3.2% | -5.4% | 7.9% | 4.4% | 0.8% | 3.0% | 6.1% | | 4.0% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 0.22 | 0.12 | 0.14 | 0.31 | (0.49) | 0.75 | 0.40 | 0.09 | 0.40 | 0.78 | | 0.53 |
Diluted EPS (Continuing Ops) | 0.22 | 0.12 | 0.14 | 0.31 | (0.49) | 0.75 | 0.40 | 0.09 | 0.40 | 0.78 | | 0.53 |
| | | | | | | | | | | | |
WA Basic Shares Out. | 420.75 | 416.90 | 431.60 | 421.87 | 447.06 | 470.81 | 466.66 | 445.97 | 445.81 | 462.44 | | 564.89 |
WA Diluted Shares Out. | 420.75 | 416.90 | 431.60 | 421.87 | 447.06 | 470.81 | 466.66 | 445.97 | 445.81 | 462.44 | | 564.89 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 107 | 59 | 63 | 154 | (268) | 378 | 199 | 16 | 163 | 350 | | 280 |
Addback: Net Interest Expense | 25 | 22 | 21 | (0) | 49 | (80) | 17 | 17 | 16 | (112) | | (44) |
Addback: Other Non Operating Expenses, Total | 2 | (2) | (15) | 28 | 58 | (2) | 37 | 15 | (70) | (11) | | 27 |
Addback: Depreciation & Amortization | 60 | 71 | 88 | 97 | 122 | 128 | 125 | 125 | 142 | 141 | | 141 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 9 | 4 | 8 | 1 | 77 | (36) | 1 | 0 | 10 | (9) | | (7) |
Addback: Gain (Loss) On Sale Of Assets | 2 | 5 | 5 | 0 | (4) | (6) | (5) | (8) | (2) | (5) | | (2) |
Addback: Asset Writedown | 5 | 0 | 25 | 16 | 30 | 57 | 21 | 3 | 5 | 6 | | (6) |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 18 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | (14) | (13) | (31) | (40) | (31) | (28) | (54) | (21) | (27) | (24) | | (28) |
Adjusted EBITDA | 197 | 147 | 164 | 256 | 31 | 429 | 342 | 148 | 236 | 337 | | 361 |
% Margin | 9.8% | 6.6% | 6.4% | 6.3% | 0.8% | 9.6% | 8.0% | 3.1% | 3.9% | 5.7% | | 4.9% |
| | | | | | | | | | | | |
Adjusted EBIT | 137 | 76 | 76 | 159 | (90) | 301 | 217 | 23 | 94 | 195 | | 220 |
% Margin | 6.8% | 3.4% | 3.0% | 3.9% | -2.2% | 6.8% | 5.1% | 0.5% | 1.6% | 3.3% | | 3.0% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 91 | 44 | 55 | 128 | (221) | 350 | 187 | 40 | 179 | 361 | | 293 |
Addback: Unusual Items | 2 | (3) | 7 | (23) | 72 | 4 | (37) | (26) | (14) | (33) | | (43) |
Less: Tax Benefit of Unusual Items (26%) | (1) | 1 | (2) | 6 | (19) | (1) | 10 | 7 | 4 | 8 | | 11 |
Adjusted Net Income | 92 | 42 | 61 | 111 | (167) | 353 | 160 | 21 | 169 | 337 | | 261 |
% Margin | 4.6% | 1.9% | 2.4% | 2.7% | -4.1% | 7.9% | 3.8% | 0.4% | 2.8% | 5.7% | | 3.6% |